Cerebral palsy · women at risk of preterm birth
Dexamethasone showed no clear difference in cerebral palsy compared with betamethasone – child outcomes (low certainty).
1 finding from 1 review
Cerebral palsy · Pregnant women undergoing fetal assessment during labour
Continuous CTG showed no clear difference in cerebral palsy compared with intermittent auscultation (low certainty).
1 finding from 1 review
Cerebral palsy · women in established labour and their babies.
1 finding from 1 review
Cerebral palsy · women in established labour and their babies.
1 finding from 1 review
Cerebral palsy · women in established labour and their babies.
1 finding from 1 review
Cerebral palsy · infants with perinatal asphyxia
It is very uncertain whether barbiturate treatment changes cerebral palsy compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Cerebral Palsy · Neonates with PPHN
1 finding from 1 review
no estimate extracted
37 participants
Low
Intervention not reported
Cerebral palsy · preterm or low birth weight infants
The intervention showed no clear difference in cerebral palsy (moderate certainty).
1 finding from 1 review
Cerebral palsy · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cerebral palsy in infancy · late preterm or term newborns with hypoxic‐ischaemic encephalopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cerebral palsy · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate leads to lower cerebral palsy (up to 2 years' corrected age)** compared with placebo (outcomes (high certainty).
2 findings from 1 review
Cerebral palsy ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cerebral palsy · preterm infants
1 finding from 1 review
Cerebral palsy · promoting short‐term growth of preterm infants
1 finding from 1 review
Cerebral palsy · preventing bronchopulmonary dysplasia in preterm infants
Early systemic postnatal corticosteroids leads to higher cerebral palsy at latest reported age compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Individual tailored showed no clear difference in death or cerebral palsy at 1 to 3 years compared with continuous tapered dexamethasone regimen (moderate certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Lower showed no clear difference in death or cerebral palsy at 1 to 3 years compared with higher cumulative dose dexamethasone regimen (low certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Later showed no clear difference in death or cerebral palsy at 1 to 3 years compared with earlier initiation of dexamethasone therapy (low certainty).
1 finding from 1 review
Cerebral palsy · preterm infants with chronic lung disease
Systemic corticosteroids (dexamethasone or hydrocortisone) showed no clear difference in cerebral palsy ‐ at latest reported age compared with control (placebo or nothing) (high certainty).
1 finding from 1 review
Cerebral palsy · very preterm or very low birth weight infants
1 finding from 1 review